Related Experiment Videos
Operative indications for patients with refractory or severe ulcerative colitis
Tomoyuki Tsujikawa1, Akira Andoh, Masaya Sakaki
1Division of Gastroenterology, Shiga University of Medical Science, Shiga, Japan. tujikawa@belle.shiga-med.ac.jp
Hepato-Gastroenterology
|October 6, 2005
Summary
Emergency colectomies for severe ulcerative colitis (UC) are decreasing due to new therapies. However, careful monitoring of steroid side effects in refractory UC patients is crucial.
Area of Science:
- Gastroenterology
- Surgical Gastroenterology
- Clinical Medicine
Background:
- Severe ulcerative colitis (UC) can necessitate emergency colectomy.
- New treatments like cyclosporin A and leukocytapheresis offer alternatives.
- Analyzing operative indications for UC is essential.
Purpose of the Study:
- To analyze historical changes in operative indications for ulcerative colitis (UC).
- To evaluate the impact of new therapies on surgical interventions for UC.
- To assess trends in medical treatment for severe and refractory UC.
Main Methods:
- Retrospective review of 40 patients undergoing surgery for UC.
- Analysis of medical treatments categorized by urgent/elective surgery.
- Comparison of treatment data across two time periods (1986-1999 and 2000-2003).
Main Results:
- Fewer patients underwent surgery for severe UC from 2000-2003 compared to 1986-1999.
- Reduced duration and total amount of steroid therapy observed in recent years.
- 40% of refractory UC patients received only steroid treatment, with decreased high-dose therapy duration.
- Postoperative patient feedback indicated a perception of delayed surgery in about half of cases.
Conclusions:
- The incidence of emergency colectomies for severe UC is declining with novel therapeutic introductions.
- Gastroenterologists must remain vigilant regarding potential adverse effects of steroid use in refractory UC.
- The study highlights evolving treatment paradigms and patient perspectives in UC management.